A Study to Examine the Safety and Tolerability of Single Ascending Doses of REGN2477

Clinical trial NCT02870400 · COMPLETED

Trial details

NCT number: NCT02870400
Sponsor: Regeneron Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2016-07-01
Primary completion: 2017-01-12
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.